Abstract
The effects of angiotensin converting enzyme inhibitors (ACEI) on proteinuria, renal function, and serum proteins were evaluated in six children with steroid-resistant nephrotic syndrome and proteinuria of 3–15 g/24h (277±47 mg/m2 per hour). Following ACEI, proteinuria decreased from 7,408±2,385 (mean±SEM) to 3,746±1,395 mg/24 h (P<0.05). Creatinine clearance was 87.8±22.6 before and 96.4±23.6 ml/min per 1.73 m2 after ACEI. In two patients, inulin and para-aminohippuric acid clearances were normal before and after ACEI, together with parallel reductions of urine protein of 50% and 46%. Clearance of total protein was reduced by 56% following ACEI, compared with reduction in the clearance of gamma globulin by 58% and albumin by 39.5%. No significant change was seen in blood pressure, serum albumin, or total protein following ACEI. After ACEI, diuretic doses were able to be reduced or eliminated in three patients. Reduction of proteinuria was sustained during a followup period of 11–20 months in three patients. ACEI may be of benefit in the clinical management of children with steroidresistant nephrotic syndromes, allowing reduction in diuretic requirements.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bernard DB (1988) Extrarenal complications of the nephrotic syndrome. Kidney Int 33: 1184–1202
Velosa JA, Holley KE, Torres VE, Offord KP (1983) Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 58: 568–577
Beaufils H, Alphonse JC, Guedon J, Legrain M (1978) Focal glomerulosclerosis: natural history and treatment: a report of 70 cases. Nephron 21: 75–85
Korbet SM, Schwartz MM, Lewis EJ (1986) The prognosis of focal segmental glomerular sclerosis of adulthood. Medicine 65: 304–311
Whelton A, Stout RL, Spilman PS, Klassen DK (1990) Renal effects of ibuprofen, priroxicam, and sulindac in patients with asymptomatic renal failure. Ann Intern Med 112: 568–576
Walser M (1990) Progression of chronic renal failure in man. Kidney Int 37: 1195–1210
Abraham PA, Opsahl JA, Halstenson CE, Keane WF (1988) Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency. Arch Interm Med 148: 2358–2362
Mazzuca N, Bigazzi R, Paparatto P, Setti GP, Valtriani C, Falciani C, Chiapponi I, Bianchi S, Morini V, Baldari G (1988) Effects of enalapril on urinary protein excretion of essential and renal parenchymal hypertensive patients. J Nucl Med Allied Sci 32: 75–81
Taguma Y, Kitamoto Y, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y (1985) Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313: 1617–1620
Kisch ES (1987) Captopril and proteinuria in diabetes mellitus. Isr J Med Sci 23: 833–834
Lagrue G, Robeva R, Laurent J (1987) Antiproteinuric effect of captopril in primary glomerular disease. Nephron 46: 99–100
Keane WF, Anderson S, Aurell M, Zeeuw D de, Narins RG, Povar G (1989) Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann Intern Med 111: 503–516
Trachtman H, Gauthier B (1988) Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease. J Pediatr 112: 295–298
Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–265
Duarte CG, Elveback LR, Liedtke RR (1980) Glomerular filtration rate and renal plasma flow. In: Duarte CG, Boston MD (eds) Renal function tests: clinical laboratory procedures and diagnosis. Little, Brown, Boston, pp 29–47
Anderson S, Brenner BM (1987) Therapeutic implications of converting-enzyme inhibitors in renal disease. Am J Kidney Dis 10: 81–87
Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G (1990) Angiotenin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541–549
Heeg JE, Jong PE de, Van Der Hem GK, Zeeuw D de (1987) Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 32: 78–83
Anderson S, Diamond JR, Karnovsky MJ, Brenner BM (1988) Mechanisms underlying transition from acute glomerular injury to glomerulosclerosis in a rat model of nephrotic syndrome. J Clin Invest 82: 1757–1768
Meyer TW, Anderson S, Rennke HG, Brenner BM (1987) Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 31: 752–759
Yoshioka T, Mitarai T, Kon V, Deen WM, Rennke HG, Ichikawa I (1986) Role for angiotensin-II in overt proteinuria. Kidney Int 30: 538–545
Schuster VL, Kokko JP, Jacobsen HR (1984) Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J Clin Invest 73: 507–515
Harris PJ, Navar LG (1985) Tubular transport responses to angiotensin. Am J Physiol 248: F621-F630
Liu FY, Cogan MG (1987) Angiotensin II. A potent regulator of acidification in the rat early proximal convoluted tubule. J Clin Invest 80: 273–275
Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ (1990) In situ hybridization evidence for antiotensinogen messenger RNA in the rat proximal tubule. J Clin Invest 85: 417–423
Taugner RF, Hackenthal E, Rix E, Nobiling R, Paulsen K (1987) Immunocytochemistry of the renin angiotensin system: renin, angiotensinogen, angiotensin I, angiotensin II, and converting enzyme in the kidneys of mice, rats, and tree shrews. Kidney Int 22: S33-S43
Ingelfinger J, Anderson S, Hirsch A, Bouyounes B, Brenner BM (1990) Renal angiotensin converting enzyme (ACE) activity is related to degree of proteinuria in active puromycin nephrosis (PAN). Pediatr Res 27: 330A
Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM (1986) Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925–1930
Hostetter HT, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the indication and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380
Brenner BM, Meyer TW, Hostether TH (1982) Dietary protein intake and progressive nature of kidney disease: the role of hemodynamically mediated injury in the pathogenesis of progressive glomerular sclerosing in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652–659
Fitzwater DS, Brouhard BH, Cunningham RJ (1990) Use of angiotensin converting enzyme inhibitors for the treatment of focal segmental glomerulosclerosis. Am J Dis Child 144: 522
Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M (1986) Beneficial effect of angiotensin converting enzyme inhibitor on renal function in patients with diabetic nephropathy. Br Med J 293: 471–474
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Milliner, D.S., Morgenstern, B.Z. Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 5, 587–590 (1991). https://doi.org/10.1007/BF00856646
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00856646